Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aster DM Healthcare Limited (ASTERDM.NS)
Dubai, AE
Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified services. It delivers a comprehensive range of medical care, from fundamental primary care to highly specialized quaternary services, supported by a vast infrastructure. This network includes 29 hospitals, 120 clinics, 371 retail pharmacies, 114 laboratories, and numerous patient experience centers, all operating under well-known brands such as Aster, Medcare, and Access. Beyond direct patient care, the company also provides healthcare retailing, diagnostic testing, digital health solutions, and medical education. Established in 1987, Aster DM Healthcare maintains its corporate headquarters in Dubai, United Arab Emirates.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.58% | +0.34% | +11.39% | +23.67% | +10.21% | +20.27% | +34.87% | +190.94% | +382.85% | +308.65% | +308.65% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+14.1% ★ Q1'26: +27.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-93.0% Q1'26: +71.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+6.0% ★ Q1'26: +7.4% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+13.7% ★ Q1'26: +14.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+8.3% ★ Q1'26: +10.9% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+3.5% Q1'26: +3.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.46× ★ Q1'26: 2.39× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 9 Rev. Ana. 6 EPS Ana. |
Mar 2027 4 Rev. Ana. 4 EPS Ana. |
Mar 2028 4 Rev. Ana. 4 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
66.23B
est: 67.21B (-1.5%)
|
78.00B
est: 79.72B (-2.2%)
|
84.51B
est: 87.69B (-3.6%)
|
85.23B
est: 87.99B (-3.1%)
|
102.53B
est: 102.01B (+0.5%)
|
29.52B
est: 119.37B (-75.3%)
|
36.38B
est: 38.60B (-5.7%)
|
40.69B
est: 42.31B (-3.8%)
|
46.26B
45.67B – 47.92B
+9.3% YoY
|
57.26B
53.20B – 59.41B
+23.8% YoY
|
69.81B
67.29B – 71.88B
+21.9% YoY
|
94.26B
89.38B – 97.39B
+35.0% YoY
|
| EBITDA |
7.78B
est: 8.92B (-12.8%)
|
8.76B
est: 10.58B (-17.2%)
|
12.30B
est: 5.92B (+107.7%)
|
11.15B
est: 5.74B (+94.3%)
|
15.34B
est: 6.62B (+131.9%)
|
4.73B
est: 6.97B (-32.2%)
|
5.87B
est: 6.70B (-12.4%)
|
8.27B
est: 7.34B (+12.8%)
|
8.04B
7.93B – 8.32B
+9.5% YoY
|
9.95B
9.24B – 10.32B
+23.8% YoY
|
12.13B
11.69B – 12.49B
+21.9% YoY
|
16.38B
15.53B – 16.92B
+35.0% YoY
|
| EBIT |
4.80B
est: 5.94B (-19.1%)
|
5.69B
est: 7.04B (-19.2%)
|
6.44B
est: 6.18B (+4.1%)
|
4.97B
est: 6.56B (-24.2%)
|
8.94B
est: 7.56B (+18.2%)
|
2.81B
est: 7.97B (-64.8%)
|
3.67B
est: 4.34B (-15.4%)
|
5.79B
est: 4.75B (+21.8%)
|
5.20B
5.14B – 5.39B
+9.5% YoY
|
6.44B
5.99B – 6.68B
+23.8% YoY
|
7.85B
7.57B – 8.09B
+21.9% YoY
|
10.61B
10.06B – 10.96B
+35.0% YoY
|
| Net Income |
2.69B
est: 1.60B (+68.3%)
|
3.33B
est: 2.21B (+50.6%)
|
2.77B
est: 3.70B (-25.2%)
|
1.48B
est: 2.78B (-46.8%)
|
5.26B
est: 3.21B (+64.0%)
|
4.25B
est: 3.61B (+17.6%)
|
1.29B
est: 1.67B (-22.4%)
|
53.78B
est: 3.18B (+1,590.2%)
|
3.88B
3.20B – 4.11B
+22.0% YoY
|
6.35B
4.97B – 7.73B
+63.6% YoY
|
8.96B
7.60B – 10.32B
+41.1% YoY
|
8.92B
8.42B – 9.42B
-0.5% YoY
|
| SGA |
4.22B
est: 13.20B (-68.0%)
|
4.34B
est: 15.66B (-72.3%)
|
8.83B
est: 39.13B (-77.4%)
|
8.04B
est: 38.92B (-79.3%)
|
10.73B
est: 44.90B (-76.1%)
|
7.55B
est: 47.32B (-84.0%)
|
9.83B
est: 8.26B (+19.0%)
|
11.00B
est: 9.06B (+21.5%)
|
9.90B
9.78B – 10.26B
+9.3% YoY
|
12.26B
11.39B – 12.72B
+23.8% YoY
|
14.94B
14.40B – 15.39B
+21.9% YoY
|
20.18B
19.13B – 20.85B
+35.0% YoY
|
| EPS |
5.75
est: 3.20 (+79.4%)
|
6.63
est: 4.44 (+49.5%)
|
5.51
est: 4.66 (+18.3%)
|
2.97
est: 2.33 (+27.5%)
|
10.58
est: 7.89 (+34.2%)
|
8.54
est: 6.52 (+30.9%)
|
2.60
est: 3.14 (-17.1%)
|
107.99
est: 6.53 (+1,554.1%)
|
7.01
6.21 – 7.97
+7.4% YoY
|
12.18
9.63 – 14.98
+73.8% YoY
|
16.29
14.73 – 19.99
+33.7% YoY
|
17.49
16.31 – 18.24
+7.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.07% | 30.5K | 0.54% |
| 2 | WisdomTree India Earnings Fund EPI | 0.06% | 1.27M | 0.84% |
| 3 | WisdomTree True Emerging Markets Fund XC | 0.06% | 47.8K | 0.32% |
| 4 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.05% | 824.0K | 0.58% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mandayapurath Azad Moopen DTCD MBBS | Founder, MD & Executive Chairman | 95M | — |
| Alisha Moopen | Deputy MD & Executive Director | 3M | female |
| Hitesh Dhaddha | Chief of Investor Relations and Merger & Amalgamation | — | male |
| Jake Barnard | Group General Counsel | — | male |
| N. Prashanth | Chief Executive Officer of Karnataka Cluster | — | — |
| S. Ramesh Kumar | Group Chief Operating Officer | — | male |
| Sudeep Dey | Chief Information & Information Security Officer | — | male |
| Sunil Kumar | Chief Financial Officer | — | male |
| Thadathil Joseph Wilson | Group Head of Governance & Corporate Affairs and Non-Executive Non-Independent Director | — | male |
| Hemish Purushottam | Company Secretary & Compliance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ASTERDM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
